Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting RNA-binding proteins with small molecules: perspectives and challenges. | Front Chem | 2025 | 41112581 | PubTator, text mining | PubMed |
| Genotyping sequence-resolved copy number variation using pangenomes reveals paralog-specific global diversity and expression divergence of duplicated genes. | Nat Genet | 2025 | 41107550 | PubTator, text mining | PubMed |
| [A study on the conversion between SMN1 and SMN2 genes]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2025 | 41070647 | PubTator, text mining | PubMed |
| [Results in our symptomatic and presymptomatic SMA patients treated with disease-modifying therapy]. | Ideggyogy Sz | 2025 | 41031558 | PubTator, text mining | PubMed |
| Inhibition of acid sphingomyelinase increases SMN levels and connects sphingolipid metabolism to Spinal Muscular Atrophy. | Biomed Pharmacother | 2025 | 41027372 | PubTator, text mining | PubMed |
| Pediatric acute respiratory distress syndrome in children with type I - spinal muscular atrophy: a 12-year case series. | Eur J Pediatr | 2025 | 41016950 | PubTator, text mining | PubMed |
| Editorial: Special Issue "Genetic Newborn Screening". | Genes (Basel) | 2025 | 41009951 | PubTator, text mining | PubMed |
| Neurofilaments as Biomarkers of the Efficacy of Risdiplam Treatment in Early SMA Phenotypes Diagnosed by Newborn Screening. | Children (Basel) | 2025 | 41007035 | PubTator, text mining | PubMed |
| Optimized Homologous Sequence Alignment for the Identification of CYP21A2 Variants in 21-Hydroxylase Deficiency Using Next-Generation Sequencing Technology. | Risk Manag Healthc Policy | 2025 | 40980470 | PubTator, text mining | PubMed |
| MVRBind: multi-view learning for RNA-small molecule binding site prediction. | Brief Bioinform | 2025 | 40977268 | PubTator, text mining | PubMed |
| Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy. | J Clin Invest | 2025 | 40956616 | PubTator, text mining | PubMed |
| The effect of thoracolumbosacral orthosis on scoliosis progression and chest deformity in children with type 1 spinal muscular atrophy: A randomized controlled trial. | PLoS One | 2025 | 40953000 | PubTator, text mining | PubMed |
| Antenatal Ultrasound Findings in Spinal Muscular Atrophy Type 0. | Mol Genet Genomic Med | 2025 | 40923389 | PubTator, text mining | PubMed |
| Cumulative motor index in spinal muscular atrophy after gene therapy: baseline predicts maximal recovery. | Clin Neurophysiol | 2025 | 40896931 | PubTator, text mining | PubMed |
| Advancing personalized spinal muscular atrophy care: matching the right biomarker to the right patient at the right time. | J Neurol | 2025 | 40892138 | PubTator, text mining | PubMed |
| The RNA revolution in medicine: from gene regulation to clinical therapeutics. | Anim Cells Syst (Seoul) | 2025 | 40874255 | PubTator, text mining | PubMed |
| Genotype Structure Alterations in 5q SMA Patients as a Result of the Newborn Screening Program Implementation in the Russian Federation. | Int J Mol Sci | 2025 | 40869213 | PubTator, text mining | PubMed |
| Transforming Spinal Muscular Atrophy: From Pivotal Trials to Real-World Evidence and Future Therapeutic Frontiers in Types 1 and 2. | Biomedicines | 2025 | 40868194 | PubTator, text mining | PubMed |
| Elevated Urinary Titin in Adult Spinal Muscular Atrophy: A Multicenter, Cross-Sectional Observational Study. | Neurol Int | 2025 | 40863983 | PubTator, text mining | PubMed |
| Partners in Silencing: Decoding the Mammalian Argonaute Interactome. | Noncoding RNA | 2025 | 40863728 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=8